Search Results 801-810 of 24225 for B cell lymphomas
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. In the Loop ...
... Cellular therapy, B-cell lymphoma, ...Lymphoma, Diffuse large b-cell lymphoma, Hairy cell leukemia, Non-Hodgkin lymphoma, T-cell lymphoma, Cutaneous t-cell ...
It is also used together with other medicines to treat diffuse large B-cell lymphoma (DLBCL) in people who have not received previous treatment. Rituximab ...
... B-cell lymphoma (rrDLBCL) in up to 138 participants from multiple sites. During an initial Dose Evaluation phase (first 2 cycles) to determine Dose Limiting ...
... B-cell lymphoma (DLBCL) that has come back or did not respond to previous treatment in patients who cannot receive a stem cell transplant. This medicine is ...
... B-cell lymphoma 2 (BCL2) inhibitor. Tissue and Blood Registry for Individuals with Liver and Biliary Tumors. Jacksonville, Fla. This study will collect and ...
D. Radiation Oncology Medical Physicist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Breast cancer, Cutaneous t-cell lymphoma, Prostate cancer, Eye ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!